Table 1.

Animal distribution chart for in vivo antidiabetic activity study

Group	No. of animals	Vehicle	Drug/dose/route	Name of group
I	6	0.3% CMC suspension	10 ml/kg/b wt; p.o	Vehicle control (+ve control)
II	6		STZ 60 mg/kg + NIC 120 mg/kg b wt; i.p.	STZ induced (−ve control)
III	6		MECP (50 mg/kg p.o.)	Test dose 1
IV	6		MECP (100 mg/kg p.o.)	Test dose 2
V	6		MECP (200 mg/kg p.o.)	Test dose 3
VI	6		Glibenclamide (10 mg/kg p.o.)	Standard control